Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2015 1
2016 1
2017 1
2018 1
2020 1
2022 8
2023 3
2024 5
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients.
Poolchanuan P, Matsee W, Dulsuk A, Phunpang R, Runcharoen C, Boonprakob T, Hemtong O, Chowplijit S, Chuapaknam V, Siripoon T, Pisutsan P, Piyaphanee W, Khongsiri W, Kosoltanapiwat N, Tan LV, Dunachie S, Tan CW, Wang LF, Chantratita W, Luvira V, Chantratita N; SEACOVARIANTS. Poolchanuan P, et al. Sci Rep. 2025 May 6;15(1):15831. doi: 10.1038/s41598-025-98627-3. Sci Rep. 2025. PMID: 40328892 Free PMC article.
Omicron BA.1, BA.2 and COVID-19 Booster Vaccination.
Assawakosri S, Kanokudom S, Suntronwong N, Puenpa J, Duangchinda T, Chantima W, Pakchotanon P, Mongkolsapaya J, Wanlapakorn N, Honsawek S, Poovorawan Y. Assawakosri S, et al. Among authors: chantima w. J Infect Dis. 2022 Oct 17;226(8):1480-1481. doi: 10.1093/infdis/jiac158. J Infect Dis. 2022. PMID: 35481828 Free PMC article. No abstract available.
Neutralizing antibodies against Omicron BA.5 among children with infection alone, vaccination alone, and hybrid immunity.
Suntronwong N, Kanokudom S, Assawakosri S, Vichaiwattana P, Klinfueng S, Phowatthanasathian H, Chansaenroj J, Srimuan D, Thatsanathorn T, Duangchinda T, Chantima W, Pakchotanon P, Sudhinaraset N, Wanlapakorn N, Poovorawan Y. Suntronwong N, et al. Among authors: chantima w. Int J Infect Dis. 2023 Sep;134:18-22. doi: 10.1016/j.ijid.2023.05.005. Epub 2023 May 18. Int J Infect Dis. 2023. PMID: 37207716 Free article.
Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated COVID-19 vaccine followed by an mRNA vaccine in children aged 5-11 years.
Wanlapakorn N, Kanokudom S, Phowatthanasathian H, Chansaenroj J, Suntronwong N, Assawakosri S, Yorsaeng R, Nilyanimit P, Vichaiwattana P, Klinfueng S, Thongmee T, Aeemjinda R, Khanarat N, Srimuan D, Thatsanatorn T, Chantima W, Pakchotanon P, Duangchinda T, Sudhinaraset N, Poovorawan Y. Wanlapakorn N, et al. Among authors: chantima w. J Med Virol. 2023 May;95(5):e28758. doi: 10.1002/jmv.28758. J Med Virol. 2023. PMID: 37212319
Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine.
Kanokudom S, Assawakosri S, Suntronwong N, Chansaenroj J, Auphimai C, Nilyanimit P, Vichaiwattana P, Thongmee T, Yorsaeng R, Duangchinda T, Chantima W, Pakchotanon P, Srimuan D, Thatsanatorn T, Klinfueng S, Mongkolsapaya J, Sudhinaraset N, Wanlapakorn N, Honsawek S, Poovorawan Y. Kanokudom S, et al. Among authors: chantima w. Vaccine. 2022 Sep 16;40(39):5657-5663. doi: 10.1016/j.vaccine.2022.08.033. Epub 2022 Aug 22. Vaccine. 2022. PMID: 36031500 Free PMC article.
Safety and antibody responses of Omicron BA.4/5 bivalent booster vaccine among hybrid immunity with diverse vaccination histories: A cohort study.
Kanokudom S, Chansaenroj J, Suntronwong N, Wongsrisang L, Aeemjinda R, Vichaiwattana P, Thatsanathorn T, Chantima W, Pakchotanon P, Duangchinda T, Sudhinaraset N, Honsawek S, Poovorawan Y. Kanokudom S, et al. Among authors: chantima w. Vaccine X. 2024 Jul 28;20:100538. doi: 10.1016/j.jvacx.2024.100538. eCollection 2024 Oct. Vaccine X. 2024. PMID: 39211731 Free PMC article.
Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3-4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination.
Assawakosri S, Kanokudom S, Suntronwong N, Chansaenroj J, Auphimai C, Nilyanimit P, Vichaiwattana P, Thongmee T, Duangchinda T, Chantima W, Pakchotanon P, Srimuan D, Thatsanathorn T, Klinfueng S, Sudhinaraset N, Wanlapakorn N, Mongkolsapaya J, Honsawek S, Poovorawan Y. Assawakosri S, et al. Among authors: chantima w. Heliyon. 2023 Dec 20;10(1):e23892. doi: 10.1016/j.heliyon.2023.e23892. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38226248 Free PMC article.
24 results